Research shows that diabetes mellitus (DM) type 2 is a progressive disease, ie disease progression will continue as though given medication, regular exercise, appropriate diet and others. This is evident from the demand for drugs continues to increase in number or kind such as the development of diabetes. The most important thing we do is how to realize and governance so that optimal diabetes mellitus disease process can be inhibited, and cell and organ damage that occurs over a little, so it can delay the occurrence of diabetic complications.
Governance is what distinguishes a person who holds a diabetic since 20 years ago still remains under control without significant complications, while others became diabetic for 5 years but had suffered a heart attack, heart failure, kidney leak, paralysis due to stroke, blindness, leg pain , amputees and others. Research in western countries indicate that the disease process has lasted for 9-12 years before a person diagnosed with diabetes, it's just that there has been no complaint.
Increased levels of blood glucose and blood fat in the long term, will cause damage to the insulin factory pancreatic beta cells, the body no longer able to offset the rise in blood glucose levels, and blood glucose levels remain high despite medication dosage has been increased even up to a maximum dose. Implementation of meal planning for diabetes day-to-day not only in theory whether the food portions are in accordance with 3 principles, namely the number of calories to eat, foods, eat a regular schedule.
Regularity of taking medications according to instructions, proper education of health personnel, a physician who is trusted by patients. Drug selection and dosage by the doctor, of course, is based on the results of periodic monitoring of diabetes, and complications influenced by the presence or absence of comorbidities such as liver disease, kidney, or pre-existing heart and not due to diabetes.
If governance is done well, but the target has not been reached, let us baranjak on pharmacological approaches (drugs) are more intensive, higher blood glucose levels 213 mg / dL is still considered high, while the target was 110mg/dL (medium) or under 100/mg/dL (best) without causing side effects hypoglikemia, the addition of another type of oral medication or insulin is injected once a day (called basal insulin) can be considered.
Evaluation of treatment outcomes of DM is most important is to check HbA1c or A1c, this result will give an idea of how the average glucose for 2-3 months, and this value is more important than just check blood glucose, fasting or after meals.
(Note: you like to comment, please write your comment in the comments below. Thank you.)
No comments:
Post a Comment